Key facts
- It has raised $500K; the latest was Early Stage VC in Sep 2025.
- Notable investors include Y Combinator, Rebel Fund, ZAKA VC, Maiora Ventures, GFT Ventures — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Avelis
- ·The full record, as it builds
Funding rounds
No funding rounds for Avelis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Avelis
Developer of a medical claims auditing platform designed to automate the process of reviewing and correcting medical bills. The company's platform utilizes machine learning models and AI agents in real time, identifies billing and coding errors, and automates the retrieval of medical records to help recover overpaid claims, enabling employers and healthcare providers to achieve significant cost savings and improve overall financial efficiency.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 3
- Website
- avelishealth.com/
- Ownership
- Privately Held (backing)
Avelis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Avelis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Avelis in its N-PORT filings yet. We sweep new filings monthly.